News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
News|Articles|March 3, 2005

Nanoparticle Synthesis Process Facilitates Chiral Separations

Nanoparticle Synthesis Process Facilitates Chiral Separations

Advertisement

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Advertisement

Related Content

Advertisement

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

ByFeliza Mirasol,Patrick Lavery
November 19th 2025

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

ByFeliza Mirasol,Patrick Lavery
November 18th 2025

Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care

ByPatrick Lavery
November 18th 2025
Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com

New Targets for Clinical Trials in the European Union

ByCheryl Barton
November 18th 2025

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

ByFeliza Mirasol
November 17th 2025
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

2

Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care

3

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

4

New Targets for Clinical Trials in the European Union

5

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us